Hailong Wang is the founder of varnotech. varnotech has raised $600M in total funding. Latest round: Series B. Based in Chengdu, China.
Hailong Wang is the founder and chairman of Varnotech Biopharm, an innovative biotech company focused on vaccine research and development. The company specializes in the research, development, and industrialization of self-owned human vaccines and novel adjuvants. Founded four years ago, Varnotech Biopharm has secured ¥600 million in Series B funding, which will be used to advance clinical trials for its herpes zoster and influenza vaccines and construct production facilities.
Full founder directory · Investor directory · Company funding database · Fundraising library